Q1 Earnings Forecast for Quanterix Issued By Leerink Partnrs

Quanterix Co. (NASDAQ:QTRX) – Stock analysts at Leerink Partnrs issued their Q1 2026 earnings estimates for shares of Quanterix in a research note issued on Tuesday, January 7th. Leerink Partnrs analyst P. Souda anticipates that the company will earn ($0.25) per share for the quarter. The consensus estimate for Quanterix’s current full-year earnings is ($0.88) per share. Leerink Partnrs also issued estimates for Quanterix’s Q2 2026 earnings at ($0.20) EPS, Q3 2026 earnings at ($0.13) EPS and Q4 2026 earnings at ($0.16) EPS.

Separately, TD Cowen boosted their price objective on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a report on Wednesday, November 13th.

Quanterix Stock Performance

QTRX opened at $11.79 on Wednesday. The stock’s 50 day moving average price is $12.05 and its 200-day moving average price is $12.70. Quanterix has a one year low of $9.87 and a one year high of $29.70. The stock has a market cap of $454.20 million, a price-to-earnings ratio of -11.23 and a beta of 1.33.

Hedge Funds Weigh In On Quanterix

A number of hedge funds have recently added to or reduced their stakes in QTRX. Portolan Capital Management LLC raised its stake in shares of Quanterix by 31.4% during the third quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock valued at $32,668,000 after acquiring an additional 602,656 shares in the last quarter. Easterly Investment Partners LLC raised its position in Quanterix by 26.5% during the 3rd quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company’s stock valued at $11,355,000 after purchasing an additional 183,387 shares in the last quarter. Geode Capital Management LLC raised its position in Quanterix by 2.2% during the 3rd quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock valued at $11,131,000 after purchasing an additional 18,231 shares in the last quarter. State Street Corp lifted its holdings in shares of Quanterix by 2.2% in the 3rd quarter. State Street Corp now owns 836,443 shares of the company’s stock worth $10,840,000 after buying an additional 18,050 shares during the period. Finally, Emerald Advisers LLC grew its position in shares of Quanterix by 5.6% during the 3rd quarter. Emerald Advisers LLC now owns 719,217 shares of the company’s stock worth $9,321,000 after buying an additional 38,230 shares in the last quarter. 86.48% of the stock is currently owned by institutional investors.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.